Homeopathy
OtherIndividualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.
NCT Number: NCT05715554
A growing number of studies identify a spectrum of persistent symptoms experienced by COVID-19 patients for months after recovery. Symptoms include cough, fatigue, dyspnea, pain, and brain fog (cognitive impairment, including confusion and memory loss), which have a negative impact on daily activities. Homoeopathic practitioners from around the world have documented a number of successful cases of Post COVID treatment. Even though evidence from practice-based research is limited, the purpose of the current study was to evaluate the effect of individualized homoeopathy treatment on post-COVID syndrome.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Gyansanjeevani India, Dausa, Rajasthan, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.
Time frame: 8 weeks
Severity from 0-10 visual analog scale, where 0 is none to 10 is most severe.
Time frame: 8 weeks
Change in dyspnea using Modified Borg Scale (0 is best to 10 is wore)
Time frame: 8 weeks
Change in fatigue severity scale (0 -7 no fatigue to worse )
Time frame: 8 weeks
Saint George Respiratory Questionnaire (SGRQ)to assess the quality of life (scores ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life).
Innowage Limited
Industry
Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients: Results of a Pilot, Pragmatic, Randomized, Open Label, Controlled Trial Investigating Acceptability and Feasibility
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05846126
Behavior, COVID-19
Terrassa, Spain
View Trial DetailsNCT05841498
COVID-19, Chronic Disease
Mainz, Rhineland-Palatinate, Germany
View Trial DetailsNCT05682560
COVID-19, Chronic Disease
Miami Lakes, Florida, United States
View Trial DetailsNCT05638620
Autonomic Nervous System Diseases, Basal Ganglia Diseases
New York, United States
View Trial Details